1. Aivazyan SO, Lukyanova EG, Shiryaev YuS. Modern treatment options for drugresistant epilepsy in children. Epilepsiya Paroksizmal. Sostoyaniya. 2014;6(1):34-43. Russian.
2. Bazilevich SN. Objective factors of relative pharmacoresistance and possible causes of true pharmacoresistance in patients with epilepsy. Vestn. Ross. Voen.-Med. Akad. 2009;(2):118-123. Russian.
3. Dorofeeva NA, Nikitina LS, Zosen DV, Glazova MV, Chernigovskaya EV. Functional state of the nigrostriatal system of Krushinsky–Molodkina rats during audiogenic seizure expression. Russ. J. Genetics: Appl. Res. 2017;7(3):217-225.
4. Krylov VV, Guekht AB, Trifonov IS, Lebedeva AV, Kai-movsky IL, Sinkin MV, Grigorieva EV, Grishkina MN, Shyshkina LV, Kochetkova OO. Outcomes of surgical treatment of patients with pharmacoresistant epilepsy. Zh. Nevrol. Psikhiatr. 2016;116(9-2):13-18. doi: 10.17116/jnev-ro20161169213-18
5. Sokolova TV, Zabrodskaya YM, Paramonova NM, Dobro-gorskaya LN, Kuralbaev AK, Kasumov VR, Sitovskaya DA. Apoptosis of brain cells in epileptic focus at phapmacresistant temporal lobe epilepsy computer modeling and epidemiology. Translyats. Med. 2017;4(6):22-33. Russian.